Molecure S.A. Logo

Molecure S.A.

Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.

MOC | WAR

Overview

Corporate Details

ISIN(s):
PLONCTH00011
LEI:
2594003L11V38ZCVKZ09
Country:
Poland
Address:
Warszawa Żwirki i Wigury 101, 02-089 Warszawa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Molecure S.A. is a clinical-stage biotechnology company that discovers and develops first-in-class small molecule drugs. The company focuses on treating diseases with high unmet medical needs, primarily in oncology and inflammatory and fibrotic conditions. Leveraging its in-house medicinal chemistry and biology capabilities, Molecure targets novel and unexplored protein and mRNA targets through its proprietary discovery platform. Its business model involves advancing a diverse pipeline of drug candidates to the clinical stage before engaging in licensing agreements for late-stage development and commercialization. The company was formerly known as OncoArendi, changing its name in March 2022.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 07:56
Audit Report / Information
Raport z przeglądu SSF 30.06.2025
Polish 236.4 KB
2025-09-30 07:56
Audit Report / Information
Raport z przeglądu JSF 30.06.2025
Polish 233.4 KB
2025-09-30 07:56
Management Discussion and Analysis
Sprawozdanie Zarządu z działalności Molecure S.A. 30.06.2025
Polish 1.5 MB
2025-09-30 07:56
Interim Report
Skonsolidowane Sprawozdanie Finansowe Molecure S.A. 30.06.2025
Polish 1.1 MB
2025-09-30 07:56
Interim Report
Jednostkowe Sprawozdanie Finansowe Molecure S.A. 30.06.2025
Polish 1.2 MB
2025-09-26 17:16
Regulatory News Service
Informacja o pozytywnej ocenie wniosku Spółki w ramach ścieżki "SMART" - Projek…
Polish 2.5 KB
2025-09-23 15:18
Pre-Annual General Meeting Information
Zaktualizowane projekty uchwał
Polish 225.0 KB
2025-09-23 15:18
Pre-Annual General Meeting Information
Aktualizacja Zarządu dotycząca projektu Uchwały Nadzwyczajnego Walnego Zgromadz…
Polish 4.9 KB
2025-09-22 20:37
Pre-Annual General Meeting Information
Załącznik - Projekty uchwał
Polish 227.6 KB
2025-09-22 20:37
Pre-Annual General Meeting Information
Projekty uchwał Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
Polish 469 bytes
2025-09-22 19:26
Pre-Annual General Meeting Information
Zalącznik - Ogłoszenie
Polish 224.9 KB
2025-09-22 19:26
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
Polish 480 bytes
2025-07-05 13:28
Regulatory News Service
Komunikat KDPW w sprawie rejestracji akcji serii J - Content (PL)
Polish 551 bytes
2025-07-03 21:19
Share Issue/Capital Change
Dopuszczenie i wprowadzenie akcji do obrotu na rynku regulowanym GPW - Content …
Polish 927 bytes
2025-07-02 20:21
Share Issue/Capital Change
Warunkowa rejestracja akcji serii J w Krajowym Depozycie Papierów Wartościowych…
Polish 1.2 KB

Automate Your Workflow. Get a real-time feed of all Molecure S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Molecure S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.